THE DELAYED DIAGNOSIS OF PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS (MPN) IS COMMON AND RESULTS IN A HIGH INCIDENCE OF POTENTIALLY PREVENTABLE THROMBOTIC COMPLICATIONS

被引：0
|
作者：
Forsyth, C. [1 ]
Tiley, C. [2 ]
Wylie, B. [2 ]
Dean, M. [2 ]
Armytage, T. [2 ]
Melville, K. [2 ]
机构：
[1] Wyong Hosp, Med, Kanwal, Australia
[2] Gosford Hosp, Haematol, Gosford, Australia
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1350
引用
收藏
页码：555 / 555
页数：1
相关论文
共 40 条
  • [31] The Association Between JAK2V617F Mutation and Bone Marrow Fibrosis at Diagnosis in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms
    Ar, M. Cem
    Buyuktas, Deram
    Eskazan, A. Emre
    Aydin, Seniz Ongoren
    Tanrikulu, Eda
    Baslar, Zafer
    Buyru, A. Nur
    Ferhanoglu, Burhan
    Aydin, Yildiz
    Tuzuner, Nukhet
    Soysal, Teoman
    TURKISH JOURNAL OF HEMATOLOGY, 2012, 29 (03) : 242 - 247
  • [32] Cyclical thrombocytosis, acquired von Willebrand syndrome and aggressive non-melanoma skin cancers are common in patients with Philadelphia-negative myeloproliferative neoplasms treated with hydroxyurea
    Verner, Emma
    Forsyth, Cecily
    Grigg, Andrew
    LEUKEMIA & LYMPHOMA, 2014, 55 (05) : 1139 - 1143
  • [33] DETERMINANTS AND FREQUENCY OF THROMBOTIC AND BLEEDING COMPLICATIONS IN AN ITALIAN COHORT OF 88 PATIENTS WITH PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS (MPN): THE ROLE OF ADAMTS-13 AND VWF ACTIVITIES
    Federici, A.
    Carraro, M.
    Lattuada, A.
    Vanelli, C.
    Sciumbata, V.
    Intini, D.
    Munizza, S.
    Budde, U.
    HAEMATOLOGICA, 2013, 98 : 345 - 346
  • [34] Incidence and Impact of Activating Mutations of the RAS-RAF- MEK-ERK Pathway in Patients with Philadelphia-Negative (Ph-negative) Myeloproliferative Neoplasms (MPNs) and Myelodysplastic/Myeloproliferative Disorders-Unclassified (MDS/MPD-U)
    Santos, Fabio P. S.
    Lisboa, Bianca
    Datoguia, Tarcila S.
    Helman, Ricardo
    Pereira, Welbert Oliveira
    Puga, Renato D.
    Miyagi, Mariana
    da Mata, Evelyn H. A.
    Santucci, Rodrigo
    Perini, Guilherme F.
    Souto, Eizabeth Xisto
    Kassab, Carolina
    Padua, Leandro
    Bollman, Patricia W.
    Higashi, Marcia
    Soares, Rodolfo
    Fadel, Adriana Valente
    Musacchio, Juliane
    Schriefer, Ana Fernandes
    Salvino, Marco Aurelio
    Cordeiro De Farias, Danielle Leao
    Perobelli, Leila Martins
    Costa, Erika M. M.
    Lima, Marinus M.
    Mattos, Vinicius R. P.
    Silveira, Paulo A. A.
    Bacal, Nydia
    Guerra, Joao Carlos
    Bezerra, Alanna Mara P. S.
    Pasqualin, Denise da Cunha
    Bello, Isabel C.
    Diniz, Michelli Silva
    Nakashima, Sandra S.
    Velloso, Elvira
    Hamerschlak, Nelson
    Campregher, Paulo Vidal
    BLOOD, 2014, 124 (21)
  • [35] High JAK2V617F variant allele frequency is associated with coronary artery but not aortic valve calcifications in patients with Philadelphia-negative myeloproliferative neoplasms
    Solli, Camilla Nordheim
    Chamat-Hedemand, Sandra
    Elming, Hanne
    Ngo, Anh
    Kjaer, Lasse
    Skov, Vibe
    Sorensen, Anders Lindholm
    Ellervik, Christina
    Hasselbalch, Hans
    Bruun, Niels Eske
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (03) : 400 - 406
  • [36] Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis and Hemostasis Research (GTH)
    Iris Appelmann
    Stephan Kreher
    Stefani Parmentier
    Hans-Heinrich Wolf
    Guido Bisping
    Martin Kirschner
    Frauke Bergmann
    Kristina Schilling
    Tim H. Brümmendorf
    Petro E. Petrides
    Andreas Tiede
    Axel Matzdorff
    Martin Griesshammer
    Hanno Riess
    Steffen Koschmieder
    Annals of Hematology, 2016, 95 : 707 - 718
  • [37] PERFORMANCE AND TOXICITY OF FLAI (FLUDARABINE, CYTARABINE, IDARUBICINE) AS INDUCTION CHEMOTHERAPY FOR HIGH RISK SECONDARY ACUTE MYELOID LEUKEMIA ARISING FROM PHILADELPHIA-NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS OR MYELODYSPLASTIC SYNDROMES
    Zannier, M. E.
    Candoni, A.
    Simeone, E.
    Lazzarotto, D.
    Ventura, G.
    Zanini, F.
    Fili, C.
    Calo, L.
    Rabassi, N.
    Comuzzi, C.
    Fanin, R.
    HAEMATOLOGICA, 2017, 102 : 69 - 69
  • [38] Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis and Hemostasis Research (GTH)
    Appelmann, Iris
    Kreher, Stephan
    Parmentier, Stefani
    Wolf, Hans-Heinrich
    Bisping, Guido
    Kirschner, Martin
    Bergmann, Frauke
    Schilling, Kristina
    Bruemmendorf, Tim H.
    Petrides, Petro E.
    Tiede, Andreas
    Matzdorff, Axel
    Griesshammer, Martin
    Riess, Hanno
    Koschmieder, Steffen
    ANNALS OF HEMATOLOGY, 2016, 95 (05) : 707 - 718
  • [39] Frequency and Determinants of Thrombotic and Bleeding Complications in Ph Negative Myeloproliferative Neoplasms (MPN): The Role of Adamts-13 and VWF Activities in an Italian Cohort 0f 88 Well Characterized Patients
    Federici, Augusto B.
    Carraro, Maria C.
    Lattuada, Antonella
    Vanelli, Chiara
    Sciumbata, Veronica
    Rossi, Valentina
    Intini, Daniela
    Birindelli, Sarah
    Munizza, Sara
    Sacchi, Elisabetta
    Russo, Umberto
    Budde, Ulrich
    BLOOD, 2012, 120 (21)
  • [40] Safety and Efficacy of Combination Therapy of Interferon-Alpha2+JAK1-2 Inhibitor in the Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Preliminary Results from the Danish Combi-Trial - an Open Label, Single Arm, Non-Randomized Multicenter Phase II Study
    Mikkelsen, Stine Ulrik
    Kjaer, Lasse
    Skov, Vibe
    Bjorn, Mads Emil
    Andersen, Christen Lykkegaard
    Bjerrum, Ole Weis
    Brochmann, Nana
    El Fassi, Daniel
    Kruse, Torben A.
    Larsen, Thomas Stauffer
    Mourits-Andersen, Torben
    Nielsen, Claus Henrik
    Pallisgaard, Niels
    Thomassen, Mads
    Hasselbalch, Hans Carl
    BLOOD, 2015, 126 (23)
1234